|
1
|
Tomlins SA, Rhodes DR, Perner S,
Dhanasekaran SM, Mehra R, Sun XW, Varambally S, Cao X, Tchinda J,
Kuefer R, et al: Recurrent fusion of TMPRSS2 and ETS transcription
factor genes in prostate cancer. Science. 310:644–648. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Druker BJ, Talpaz M, Resta DJ, Peng B,
Buchdunger E, Ford JM, Lydon NB, Kantarjian H, Capdeville R,
Ohno-Jones S and Sawyers CL: Efficacy and Safety of a Specific
Inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid
leukemia. N Engl J Med. 344:1031–1037. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kumar-Sinha C, Kalyana-Sundaram S and
Chinnaiyan AM: SLC45A3-ELK4 chimera in prostate cancer: Spotlight
on cis-splicing. Cancer Discov. 2:582–585. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rickman DS, Pflueger D, Moss B, Van Doren
VE, Chen CX, de la Taille A, Kuefer R, Tewari AK, Setlur SR,
Demichelis F and Rubin MA: SLC45A3-ELK4 is a novel and frequent
erythroblast transformation-specific fusion transcript in prostate
cancer. Cancer Res. 69:2734–2738. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Maher CA, Kumar-Sinha C, Cao X,
Kalyana-Sundaram S, Han B, Jing X, Sam L, Barrette T, Palanisamy N
and Chinnaiyan AM: Transcriptome sequencing to detect gene fusions
in cancer. Nature. 458:97–101. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Seshagiri S, Stawiski EW, Durinck S,
Modrusan Z, Storm EE, Conboy CB, Chaudhuri S, Guan Y, Janakiraman
V, Jaiswal BS, et al: Recurrent R-spondin fusions in colon cancer.
Nature. 488:660–664. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang Y, Gong M, Yuan H, Park HG, Frierson
HF and Li H: Chimeric transcript generated by cis-splicing of
adjacent genes regulates prostate cancer cell proliferation. Cancer
Discov. 2:598–607. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zlatanova J and Caiafa P: CTCF and its
protein partners: Divide and rule? J Cell Sci. 122:1275–1284. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lobanenkov VV, Nicolas RH, Adler VV,
Paterson H, Klenova EM, Polotskaja AV and Goodwin GH: A novel
sequence-specific DNA binding protein which interacts with three
regularly spaced direct repeats of the CCCTC-motif in the
5′-flanking sequence of the chicken c-myc gene. Oncogene.
5:1743–1753. 1990.PubMed/NCBI
|
|
10
|
Kim TH, Abdullaev ZK, Smith AD, Ching KA,
Loukinov DI, Green RD, Zhang MQ, Lobanenkov VV and Ren B: Analysis
of the vertebrate insulator protein CTCF-binding sites in the human
genome. Cell. 128:1231–1245. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Qin F, Song Z, Babiceanu M, Song Y,
Facemire L, Singh R, Adli M and Li H: Discovery of CTCF-sensitive
Cis-spliced fusion RNAs between adjacent genes in human prostate
cells. PLoS Genet. 11:e10050012015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Vatolin S, Abdullaev Z, Pack SD, Flanagan
PT, Custer M, Loukinov DI, Pugacheva E, Hong JA, Morse H III,
Schrump DS, et al: Conditional expression of the CTCF-paralogous
transcriptional factor BORIS in normal cells results in
demethylation and derepression of MAGE-A1 and reactivation of other
cancer-testis genes. Cancer Res. 65:7751–7762. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Loukinov DI, Pugacheva E, Vatolin S, Pack
SD, Moon H, Chernukhin I, Mannan P, Larsson E, Kanduri C, Vostrov
AA, et al: BORIS, a novel male germ-line-specific protein
associated with epigenetic reprogramming events, shares the same
11-zinc-finger domain with CTCF, the insulator protein involved in
reading imprinting marks in the soma. Proc Natl Acad Sci USA.
99:pp. 6806–6811. 2002; View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hoffmann MJ, Müller M, Engers R and Schulz
WA: Epigenetic control of CTCFL/BORIS and OCT4 expression in
urogenital malignancies. Biochem Pharmacol. 72:1577–1588. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
D'Arcy V, Abdullaev ZK, Pore N, Docquier
F, Torrano V, Chernukhin I, Smart M, Farrar D, Metodiev M,
Fernandez N, et al: The potential of BORIS detected in the
leukocytes of breast cancer patients as an early marker of
tumorigenesis. Clin Cancer Res. 12:5978–5986. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
D'Arcy V, Pore N, Docquier F, Abdullaev
ZK, Chernukhin I, Kita GX, Rai S, Smart M, Farrar D, Pack S, et al:
BORIS, a paralogue of the transcription factor, CTCF, is aberrantly
expressed in breast tumours. Br J Cancer. 98:571–579. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dougherty CJ, Ichim TE, Liu L, Reznik G,
Min WP, Ghochikyan A, Agadjanyan MG and Reznik BN: Selective
apoptosis of breast cancer cells by siRNA targeting of BORIS.
Biochem Biophys Res Commun. 370:109–112. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rhodes DR, Yu J, Shanker K, Deshpande N,
Varambally R, Ghosh D, Barrette T, Pandey A and Chinnaiyan AM:
ONCOMINE: A cancer microarray database and integrated data-mining
platform. Neoplasia. 6:1–6. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Method. 25:402–408. 2001.
View Article : Google Scholar
|
|
20
|
Gao J, Aksoy BA, Dogrusoz U, Dresdner G,
Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al:
Integrative analysis of complex cancer genomics and clinical
profiles using the cBioPortal. Sci Signal. 6:pl12013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cerami E, Gao J, Dogrusoz U, Gross BE,
Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et
al: The cBio cancer genomics portal: An open platform for exploring
multidimensional cancer genomics data. Cancer Discov. 2:401–404.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rosa-Garrido M, Ceballos L, Alonso-Lecue
P, Abraira C, Delgado MD and Gandarillas A: A cell cycle role for
the epigenetic factor CTCF-L/BORIS. PLoS One. 7:e393712012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Martin-Kleiner I: BORIS in human cancers-a
review. Eur J Cancer. 48:929–935. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Weber A, Borghouts C, Brendel C, Moriggl
R, Delis N, Brill B, Vafaizadeh V and Groner B: Stat5 exerts
distinct, vital functions in the cytoplasm and nucleus of Bcr-Abl+
K562 and Jak2(V617F)+ HEL leukemia cells. Cancers. 7:503–537. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Schneider-Stock R, Diab-Assef M, Rohrbeck
A, Foltzer-Jourdainne C, Boltze C, Hartig R, Schönfeld P, Roessner
A and Gali-Muhtasib H: 5-Aza-cytidine is a potent inhibitor of DNA
methyltransferase 3a and induces apoptosis in HCT-116 colon cancer
cells via Gadd45- and p53-dependent mechanisms. J Pharmacol Exp
Ther. 312:525–536. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Rabbitts TH: Chromosomal translocations in
human cancer. Nature. 372:143–149. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Rowley JD: The role of chromosome
translocations in leukemogenesis. Semin Hematol. 36 4 Suppl
7:S59–S72. 1999.
|
|
28
|
Heim S and Mitelman F: Molecular screening
for new fusion genes in cancer. Nat Genet. 40:685–686. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yuan H, Qin F, Movassagh M, Park H, Golden
W, Xie Z, Zhang P, Sklar J and Li H: A chimeric RNA characteristic
of rhabdomyosarcoma in normal myogenesis process. Cancer Discov.
3:1394–1403. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bhan S, Negi SS, Shao C, Glazer CA, Chuang
A, Gaykalova DA, Sun W, Sidransky D, Ha PK and Califano JA: BORIS
binding to the promoters of cancer testis antigens, MAGEA2, MAGEA3,
and MAGEA4, is associated with their transcriptional activation in
lung cancer. Clin Cancer Res. 17:4267–4276. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nguyen P, Bar-Sela G, Sun L, Bisht KS, Cui
H, Kohn E, Feinberg AP and Gius D: BAT3 and SET1A form a complex
with CTCFL/BORIS to modulate H3K4 histone dimethylation and gene
expression. Mol Cell Biol. 28:6720–6729. 2008. View Article : Google Scholar : PubMed/NCBI
|
